vs

Side-by-side financial comparison of CareCloud, Inc. (CCLD) and USCB FINANCIAL HOLDINGS, INC. (USCB). Click either name above to swap in a different company.

CareCloud, Inc. is the larger business by last-quarter revenue ($34.4M vs $22.2M, roughly 1.6× USCB FINANCIAL HOLDINGS, INC.). On growth, CareCloud, Inc. posted the faster year-over-year revenue change (21.9% vs 14.7%). USCB FINANCIAL HOLDINGS, INC. produced more free cash flow last quarter ($42.5M vs $6.6M). Over the past eight quarters, CareCloud, Inc.'s revenue compounded faster (15.1% CAGR vs 12.3%).

CareCloud, Inc. is a publicly traded American healthcare information technology company that provides services, to healthcare providers and hospitals. The Company maintains its headquarters in Somerset, New Jersey, and employs approximately 4,000 workers worldwide.

USCB Financial Holdings, Inc. is a U.S.-headquartered bank holding company that offers comprehensive retail and commercial banking services, including deposit products, personal and business loans, wealth management, and digital banking tools. It primarily serves individual consumers, small and medium-sized enterprises, and local corporate clients across its operating regions in the United States, prioritizing personalized customer experiences and community-oriented financial services.

CCLD vs USCB — Head-to-Head

Bigger by revenue
CCLD
CCLD
1.6× larger
CCLD
$34.4M
$22.2M
USCB
Growing faster (revenue YoY)
CCLD
CCLD
+7.2% gap
CCLD
21.9%
14.7%
USCB
More free cash flow
USCB
USCB
$36.0M more FCF
USCB
$42.5M
$6.6M
CCLD
Faster 2-yr revenue CAGR
CCLD
CCLD
Annualised
CCLD
15.1%
12.3%
USCB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCLD
CCLD
USCB
USCB
Revenue
$34.4M
$22.2M
Net Profit
$1.4M
Gross Margin
Operating Margin
9.1%
14.7%
Net Margin
6.1%
Revenue YoY
21.9%
14.7%
Net Profit YoY
-80.3%
EPS (diluted)
$0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCLD
CCLD
USCB
USCB
Q4 25
$34.4M
$22.2M
Q3 25
$31.1M
$25.0M
Q2 25
$27.4M
$24.4M
Q1 25
$27.6M
$22.8M
Q4 24
$28.2M
$23.0M
Q3 24
$28.5M
$21.5M
Q2 24
$28.1M
$20.5M
Q1 24
$26.0M
$17.6M
Net Profit
CCLD
CCLD
USCB
USCB
Q4 25
$1.4M
Q3 25
$3.1M
$8.9M
Q2 25
$2.9M
$8.1M
Q1 25
$1.9M
$7.7M
Q4 24
$6.9M
Q3 24
$3.1M
$6.9M
Q2 24
$1.7M
$6.2M
Q1 24
$-241.0K
$4.6M
Operating Margin
CCLD
CCLD
USCB
USCB
Q4 25
9.1%
14.7%
Q3 25
10.3%
47.3%
Q2 25
10.9%
44.0%
Q1 25
7.3%
44.2%
Q4 24
12.2%
39.6%
Q3 24
11.4%
42.5%
Q2 24
8.1%
39.8%
Q1 24
0.5%
34.3%
Net Margin
CCLD
CCLD
USCB
USCB
Q4 25
6.1%
Q3 25
9.8%
35.8%
Q2 25
10.6%
33.4%
Q1 25
7.0%
33.5%
Q4 24
30.0%
Q3 24
10.9%
32.3%
Q2 24
6.0%
30.3%
Q1 24
-0.9%
26.2%
EPS (diluted)
CCLD
CCLD
USCB
USCB
Q4 25
$0.06
Q3 25
$0.04
$0.45
Q2 25
$0.04
Q1 25
$-0.04
Q4 24
$0.00
Q3 24
$-0.04
$0.35
Q2 24
$-0.14
Q1 24
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCLD
CCLD
USCB
USCB
Cash + ST InvestmentsLiquidity on hand
$38.5M
Total DebtLower is stronger
$1.2M
Stockholders' EquityBook value
$59.5M
$217.2M
Total Assets
$87.6M
$2.8B
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCLD
CCLD
USCB
USCB
Q4 25
$38.5M
Q3 25
$56.8M
Q2 25
$54.8M
Q1 25
$98.0M
Q4 24
$77.0M
Q3 24
$38.5M
Q2 24
$77.3M
Q1 24
$126.5M
Total Debt
CCLD
CCLD
USCB
USCB
Q4 25
$1.2M
Q3 25
Q2 25
Q1 25
Q4 24
$336.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CCLD
CCLD
USCB
USCB
Q4 25
$59.5M
$217.2M
Q3 25
$57.8M
$209.1M
Q2 25
$56.1M
$231.6M
Q1 25
$54.2M
$225.1M
Q4 24
$49.8M
$215.4M
Q3 24
$46.5M
$213.9M
Q2 24
$43.2M
$201.0M
Q1 24
$41.4M
$195.0M
Total Assets
CCLD
CCLD
USCB
USCB
Q4 25
$87.6M
$2.8B
Q3 25
$90.6M
$2.8B
Q2 25
$75.2M
$2.7B
Q1 25
$73.6M
$2.7B
Q4 24
$71.6M
$2.6B
Q3 24
$70.7M
$2.5B
Q2 24
$74.0M
$2.5B
Q1 24
$76.9M
$2.5B
Debt / Equity
CCLD
CCLD
USCB
USCB
Q4 25
0.02×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCLD
CCLD
USCB
USCB
Operating Cash FlowLast quarter
$8.7M
$42.8M
Free Cash FlowOCF − Capex
$6.6M
$42.5M
FCF MarginFCF / Revenue
19.0%
191.4%
Capex IntensityCapex / Revenue
6.2%
1.4%
Cash ConversionOCF / Net Profit
31.40×
TTM Free Cash FlowTrailing 4 quarters
$23.8M
$95.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCLD
CCLD
USCB
USCB
Q4 25
$8.7M
$42.8M
Q3 25
$7.4M
$20.1M
Q2 25
$7.4M
$18.0M
Q1 25
$5.1M
$14.6M
Q4 24
$5.2M
$34.8M
Q3 24
$7.1M
$11.3M
Q2 24
$4.3M
$18.3M
Q1 24
$4.1M
$8.1M
Free Cash Flow
CCLD
CCLD
USCB
USCB
Q4 25
$6.6M
$42.5M
Q3 25
$6.5M
$20.0M
Q2 25
$6.2M
$18.0M
Q1 25
$4.5M
$14.6M
Q4 24
$4.3M
$34.5M
Q3 24
$6.7M
$11.2M
Q2 24
$4.2M
$18.2M
Q1 24
$3.8M
$8.0M
FCF Margin
CCLD
CCLD
USCB
USCB
Q4 25
19.0%
191.4%
Q3 25
20.9%
80.3%
Q2 25
22.8%
73.7%
Q1 25
16.2%
63.9%
Q4 24
15.2%
150.2%
Q3 24
23.6%
52.2%
Q2 24
14.8%
88.8%
Q1 24
14.5%
45.4%
Capex Intensity
CCLD
CCLD
USCB
USCB
Q4 25
6.2%
1.4%
Q3 25
2.8%
0.5%
Q2 25
4.2%
0.2%
Q1 25
2.3%
0.2%
Q4 24
3.3%
1.4%
Q3 24
1.2%
0.4%
Q2 24
0.5%
0.4%
Q1 24
1.1%
0.5%
Cash Conversion
CCLD
CCLD
USCB
USCB
Q4 25
31.40×
Q3 25
2.41×
2.25×
Q2 25
2.55×
2.22×
Q1 25
2.62×
1.91×
Q4 24
5.05×
Q3 24
2.26×
1.63×
Q2 24
2.56×
2.95×
Q1 24
1.75×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCLD
CCLD

Healthcare IT$31.0M90%
Medical Practice Management$3.4M10%

USCB
USCB

Segment breakdown not available.

Related Comparisons